Global Health Technologies Coalition (GHTC)
banner
ghtcoalition.org
Global Health Technologies Coalition (GHTC)
@ghtcoalition.org
Our mission is to advance innovation to save lives. GHTC is the leading advocacy organization working to accelerate R&D for #GlobalHealth technologies. #Innovate4Health
Increased attention to #NTDs has fueled research breakthroughs, but significant gaps remain in the arsenal of tools needed to control and eliminate them. Learn more about past successes and tools in development. 🔬🥼

www.ghtcoalition.org/rd-across-he...
Neglected Tropical Diseases
www.ghtcoalition.org
January 16, 2026 at 5:18 PM
A team of researchers led by the University of Virginia has shared findings that could transform the treatment of #sepsis, the leading global cause of death, in Africa.

www.ghtcoalition.org/blog/researc...
Research Roundup: Functional cure for hepatitis B, Phase 1 trial of HIV vaccine approach, Sepsis treatment breakthrough
In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.
www.ghtcoalition.org
January 15, 2026 at 3:08 PM
Reposted by Global Health Technologies Coalition (GHTC)
Upcoming webinar with @IDSAinfo.bsky.social Jeanne Marrazzo, we'll explore the People's Research Agenda. Join us on Tuesday, 1/20 at 9am ET to learn what the PRA tracks, why it matters and what's at stake for the pipeline of HIV prevention R&D in 2026, and beyond. Register here:
The Future of HIV Prevention: A People’s Research Agenda for Speed, Scale and Equity
First developed in 2024 in partnership with global advocates and communities, the People’s Research Agenda sets out a people-centered framework for equitable and accelerated R&D and product…
buff.ly
January 15, 2026 at 11:45 AM
Reposted by Global Health Technologies Coalition (GHTC)
Announced in 2019, 5 BY 25 was an ambitious goal to tackle AMR. Launched today, the report shows how GARDP developed 5+ treatments focused on priority infections while strengthening antibiotic R&D, manufacturing and access.

🔗 Read the report: gardp.org/publications...
January 15, 2026 at 12:10 PM
#COVID19 vaccines saved millions of lives & $900B in direct health care costs in just the first 15 months after introduction.

That’s the power of #GlobalHealth R&D. #Innovate4Health

www.ghtcoalition.org/resources-it...
Doing well by doing good: Why investing in global health R&D benefits the United States and the world
Examines the blockbuster returns from US government investment in global health R&D, including the lifesaving tools advanced and the economic and health benefits generated globally and domestically.
www.ghtcoalition.org
January 14, 2026 at 10:29 PM
Last week, IAVI announced that the first doses of experimental #HIV vaccine antigens were administered in a Phase 1 trial designed to advance a new strategy for HIV vaccine development.

www.ghtcoalition.org/blog/researc...
Research Roundup: Functional cure for hepatitis B, Phase 1 trial of HIV vaccine approach, Sepsis treatment breakthrough
In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.
www.ghtcoalition.org
January 14, 2026 at 4:04 PM
Reposted by Global Health Technologies Coalition (GHTC)
⏰ Only a few days left to register for GARDP’s 5 BY 25 webinar.

We will discuss what the evidence from 5 BY 25 shows and how it is shaping the next phase of antibiotic R&D and access.

📅 15 Jan | 12:00–13:00 CET
🔗 https://gotowebinar.pulse.ly/sx58sweqro

#AMR #AntibioticResistance #GARDP
January 11, 2026 at 6:59 AM
Reposted by Global Health Technologies Coalition (GHTC)
⏰ Last days to submit your abstract to the #INTEREST2026 Conference!

Provide a summary of your research for the chance to present at Africa’s premier conference dedicated to HIV/AIDS in May 2026.

Abstract Submission Portal: virology.eventsair.com/Presentation...

INTEREST: interestworkshop.org
January 12, 2026 at 11:30 AM
Reposted by Global Health Technologies Coalition (GHTC)
📢New partnership on gonorrhoea

GARDP and Debiopharm are partnering to advance Debio1453, a first-in-class antibiotic candidate for Neisseria gonorrhoeae, helping sustain the antibiotic pipeline as resistance grows.

🔗 Read the PR: https://gardp.pulse.ly/0ckjycxlvh
January 13, 2026 at 1:09 PM
Reposted by Global Health Technologies Coalition (GHTC)
📘 New publication supported by CARB-X!

A new supplement in Oxford University Press Clinical Infectious Diseases highlights why treatment diversification is essential to address rising drug resistance in N. gonorrhoeae. #IDSky 🧪

🔗 Read here: bit.ly/45KVg90
January 13, 2026 at 2:02 PM
Reposted by Global Health Technologies Coalition (GHTC)
Calling all mid-career African researchers: the application deadline for the SAHRI Fellowship Programme is fast approaching. A fully funded opportunity to build leadership in biomedical innovation and clinical research. Apply by 1 February bit.ly/4qfTdT6
January 13, 2026 at 5:13 PM
Reposted by Global Health Technologies Coalition (GHTC)
Upcoming webinar with @IDSAinfo.bsky.social Jeanne Marrazzo. We'll explore the People's Research Agenda. Join us on Tuesday, 1/20 at 9am ET to learn what the PRA tracks, why it matters and what's at stake for the pipeline of HIV prevention R&D in 2026, and beyond. Register here: buff.ly/Cgtyysu
January 13, 2026 at 6:45 PM
GSK has shared the results of two highly anticipated Phase 3 studies investigating its potential “functional cure” for chronic #HepatitisB, which affects more than 250 million people worldwide and is a leading cause of liver cancer.

www.ghtcoalition.org/blog/researc...
Research Roundup: Functional cure for hepatitis B, Phase 1 trial of HIV vaccine approach, Sepsis treatment breakthrough
In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.
www.ghtcoalition.org
January 13, 2026 at 2:15 PM
What's new in #GlobalHealth R&D?
💊Functional cure for #HepatitisB
💉Phase 1 trial of #HIV vaccine approach
🥼#Sepsis treatment breakthrough

www.ghtcoalition.org/blog/researc...
Research Roundup: Functional cure for hepatitis B, Phase 1 trial of HIV vaccine approach, Sepsis treatment breakthrough
In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.
www.ghtcoalition.org
January 12, 2026 at 3:42 PM
The path from promising discovery to lifesaving technology is a long and challenging one. 🔬➡️➡️ 💊 Find out more in our interactive infographic. #GlobalHealth

www.ghtcoalition.org/pipeline-of-...
Pipeline of Promise | Global Health Technologies Coalition
Find out more about Global Health Research and Product Development Process - A Pipeline of Promise and the GOAL: Address a health need by producing a safe and effective product that is appropriate, ac...
www.ghtcoalition.org
January 9, 2026 at 4:49 PM
Reposted by Global Health Technologies Coalition (GHTC)
📢 CARB-X Novel Chemistry for AMR Challenge!
CARB-X is seeking applications for novel chemistry plans against known #AMR targets. The aim is to unlock innovative starting points for therapeutics to address drug-resistant bacterial infections. #IDSky #ChemSky 🧪
🔗 bit.ly/4blmsyN
January 8, 2026 at 2:00 PM
A research team has used an innovative robotic system to develop a possible antibiotic candidate for priority bacterial threats, as the global danger of antimicrobial resistance continues to rise. #AMR

www.ghtcoalition.org/blog/researc...
Research Roundup: AI-assisted RNA drug discovery, Rapid COVID-19 tests prequalified, New antibiotic discovery method
In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.
www.ghtcoalition.org
January 8, 2026 at 4:09 PM
#GlobalHealth R&D is a smart investment. It not only saves lives, but also promotes economic growth, generates cost savings, and advances #HealthSecurity.

www.ghtcoalition.org/why-research...
Why Research & Development | Global Health Technologies Coalition
Find out why research and development for new health technologies is an essential part of the solution to the world’s greatest global health challenges and one of the biggest drivers of health improve...
www.ghtcoalition.org
January 7, 2026 at 9:02 PM
Reposted by Global Health Technologies Coalition (GHTC)
A human hookworm vaccine is being developed by @bcmhouston.bsky.social, but a new study suggests that a combined hookworm/malaria vaccine may be preferred in endemic countries.

We interviewed stakeholders about the idea of a dual-parasite vaccine: https://bit.ly/4jivdvw

#VaccinesWork
The appeal of a dual-parasite combination vaccine
A human hookworm vaccine is under development, but a new study suggests that a combined hookworm and malaria vaccine may be preferred in endemic countries.
www.path.org
January 6, 2026 at 3:54 PM
Reposted by Global Health Technologies Coalition (GHTC)
Register now for the Global Health Institute’s webinar on the Local to Global Rise of Antimicrobial Resistance.
GARDP’s François Franceschi will join the panel alongside global health leaders.

📅 27 January 2026
⏰ 9–10am CST

🔗 Register: https://zoom.pulse.ly/dhjfoulfmd

#AMR #GlobalHealth #GARDP
Welcome! You are invited to join a webinar: UW–Madison Global Health Institute Global Health Tuesday Webinar: Local to Global Rise in Antimicrobial Resistance. After registering, you will receive a confirmation email about joining the webinar.
The Global Health Institute’s January Global Health Tuesday Webinar is scheduled for Tuesday, January 27, 2026, from 9-10am CST. Laurel Legenza, Assistant Professor, School of Nursing, UW–Madison, moderates a timely conversation on Local to Global Rise in Antimicrobial Resistance. Legenza will lead the discussion with panelists François Franceschi, Head of Asset Evaluation and Development and Serious Bacterial Infections Project Leader, Global Antibiotic Research & Development Partnership (GARDP); and Dr. Erta Kalanxhi, Director of Partnerships, One Health Trust.
zoom.pulse.ly
January 7, 2026 at 11:00 AM
Reposted by Global Health Technologies Coalition (GHTC)
Working on a project that could help expand MMV’s drug discovery pipeline and the global antimalarial toolbox? Our 23rd call for proposals is now open for compounds addressing key #malaria prevention, treatment and elimination needs. Deadline: 27 Feb. 👉 bit.ly/3XFUG8n
January 7, 2026 at 1:21 PM
The World Health Organization recently announced the prequalification of two rapid antigen tests for SARS-CoV-2, the virus that causes COVID-19, helping improve diagnostics access worldwide as the virus continues to circulate globally.

www.ghtcoalition.org/blog/researc...
Research Roundup: AI-assisted RNA drug discovery, Rapid COVID-19 tests prequalified, New antibiotic discovery method
In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.
www.ghtcoalition.org
January 7, 2026 at 2:20 PM
A recent article explores how artificial intelligence could revolutionize the development of RNA drugs, which have emerged as a promising tool across health areas, from oncology to preventive vaccines.

www.ghtcoalition.org/blog/researc...
Research Roundup: AI-assisted RNA drug discovery, Rapid COVID-19 tests prequalified, New antibiotic discovery method
In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.
www.ghtcoalition.org
January 6, 2026 at 2:15 PM
What's new in #GlobalHealth R&D?
💊AI-assisted RNA drug discovery
🧪Rapid #COVID19 tests prequalified
🧫New antibiotic discovery method

www.ghtcoalition.org/blog/researc...
Research Roundup: AI-assisted RNA drug discovery, Rapid COVID-19 tests prequalified, New antibiotic discovery method
In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.
www.ghtcoalition.org
January 5, 2026 at 9:18 PM
Reposted by Global Health Technologies Coalition (GHTC)
💻 Join GARDP’s webinar on the progress and lessons from 5 BY 25, our multi-year effort to advance new antibiotic treatments.

We will share key results shaping the next phase of antibiotic R&D and access.

📅 15 Jan | 12:00–13:00 CET

🔗 https://gotowebinar.pulse.ly/xzadk4tr7b
January 2, 2026 at 6:59 AM